14.12.2017
Immuno-oncological therapies are a new approach that position human defense systems against cancers caused by the body's own cells. A team led by Christian Becker of the Department of Biological Chemistry has now developed a new method in which the cancer cells are labeled as bacteria. This is done with a completely synthetically produced molecule, which leads to the activation of the innate immune system, which in turn efficiently prevents the formation of a tumor. These results are currently published in the renowned scientific journal "Scientific Reports".
